TCT 2014: New data boosts Medtronic's confidence in drug-coated peripheral balloon
This article was originally published in Clinica
Executive Summary
Medtronic’s efforts to get an early edge in the emerging peripheral drug-coated balloon catheter market got another boost at this year’s Transcatheter Cardiovascular Therapeutics (TCT) conference, with the release of data showing Medtronic’s IN.PACT Admiral paclitaxel-coated balloon is performing about as well in “real-world” patients as it did in clinical trials.